WORLD HEALTH ORGANIZATION EXECUTIVE BOARD 111th Session Provisional agenda item 10.1 EB111/28 Add.1 23 December 2002
Report on meetings of expert advisory panels and committees and study groups and report on appointments to expert advisory panels and committees Report by the Secretariat1
ESTABLISHMENT OR DISESTABLISHMENT OF EXPERT ADVISORY PANELS 1. The WHO Expert Advisory Panel on Human Blood Products and Related Substances was disestablished and the WHO Expert Advisory Panel on Clinical Surgical Procedures was established.
MEMBERSHIP OF THE EXPERT ADVISORY PANELS 2. Membership of the 55 expert advisory panels totalled 1185 in December 2002, compared with 1337 in December 2001. Of the regional distribution of all members of all panels, 9% come from the African Region, 23% from the Region of the Americas, 10% from the South-East Asia Region, 34% from the European Region, 9% from the Eastern Mediterranean Region and 14% from the Western Pacific Region. Of the total of all members of all panels, 19% are women. 3. Attached is a list of all panels, which includes a breakdown of members by panel, region and sex, as of December 2002. Further details (alphabetical list of experts giving nationality) can be made available should members of the Board so request.
MEETINGS OF EXPERT COMMITTEES 4. The following committees met in 2002: Joint FAO/WHO Expert Committee on Food Additives (58th Session), Geneva, 21-27 February 2002 (six WHO members: six men)
This report is submitted to the Executive Board in compliance with regulation 4.23 of the Regulations for Expert Advisory Panels and Committees.
1
EB111/28 Add.1
Expert Committee on the Selection and Use of Essential Medicines, Geneva, 15-19 April 2002 (10 members: seven men, three women) Joint FAO/WHO Expert Committee on Food Additives (59th Session), Geneva, 4-13 June 2002 (seven WHO members: five men, two women) Advisory Committee on Health Research (40th Session), Geneva, 17-19 June 2002 (14 WHO members: eleven men, three women) Expert Committee on Drug Dependence (33rd Session), Geneva, 17-20 September 2002 (10 members: eight men, two women) 5. Invitations to take part in these meetings were extended to 47 panel members from 29 different countries, drawn from 12 expert advisory panels.
AMENDMENTS TO THE REGULATIONS FOR EXPERT ADVISORY PANELS AND COMMITTEES1 6. Further to the amendments to the Regulations adopted at the Fifty-fifth World Health Assembly, nomination of experts from developing countries is encouraged by the Director-General and Regional Directors. Information on all appointments of experts to advisory panels is available to Member States and a report on this matter will be submitted to the Fifty-sixth World Health Assembly.
1
Resolution WHA55.24.
2
MEMBERSHIP OF WHO EXPERT ADVISORY PANELS BY PANEL AND REGION Numbers of panel members, as of December 2002 WHO expert advisory panels Acute bacterial diseases Acute diarrhoeal diseases and other enteric infections Ageing and health Biological standardization Blood transfusion medicine Brucellosis Cancer Cardiovascular diseases Chronic degenerative diseases (diabetes) Chronic degenerative diseases (rheumatic diseases) Clinical surgical procedures Development of human resources for health Drug dependence (dependence liability evaluation) Drug dependence and alcohol problems Drug evaluation Drug policies and management Food safety Health laboratory services Health promotion and education Health science and technology policy Health situation and trend assessment Human genetics Human reproduction Immunology Injury and violence prevention and control International pharmacopoeia and pharmaceutical preparations Leprosy Malaria Africa N 1 0 2 0 4 0 1 3 3 0 0 5 1 0 7 7 4 3 0 4 0 2 0 0 0 10 0 4 W 0 0 2 0 1 0 0 0 0 0 0 2 0 0 0 3 0 1 0 1 0 0 0 0 0 0 0 0 The Americas N W 5 1 4 9 3 1 11 6 3 1 2 4 8 3 6 6 17 9 0 6 1 7 1 7 5 11 5 2 0 0 3 3 2 0 3 1 0 0 0 1 1 2 2 1 4 2 0 1 0 1 1 0 2 8 0 0 South-East Asia N W 1 3 1 2 2 0 4 2 2 1 1 5 0 1 2 5 2 2 0 3 3 2 2 4 1 2 4 4 0 2 0 0 1 0 2 0 1 0 0 0 0 0 0 1 1 1 0 1 0 0 0 1 0 1 0 0 Europe N 11 2 11 19 8 0 11 12 7 1 1 9 2 11 11 10 18 17 0 5 4 11 2 9 3 30 5 15 W 2 0 2 2 2 0 0 1 0 1 0 0 0 3 3 5 1 3 0 0 0 1 0 0 2 10 1 0 Eastern Mediterranean N W 3 0 2 2 3 0 0 3 1 0 1 4 2 1 5 2 1 6 1 1 3 3 0 1 0 6 2 2 0 0 1 0 2 0 0 0 0 0 0 0 0 0 1 0 0 2 1 0 1 1 0 0 0 0 0 0 Western Pacific N W 2 1 1 2 4 0 5 6 2 0 0 4 4 5 5 8 4 5 0 5 1 4 2 3 1 10 1 2 1 0 0 0 1 0 1 0 0 0 0 0 1 1 1 3 0 2 0 2 0 0 2 0 0 0 0 0 Total N 23 7 21 34 24 1 32 32 18 3 5 31 17 21 36 38 46 42 1 24 12 29 7 24 10 69 17 29 W 3 2 8 5 9 0 6 2 1 1 0 3 2 6 7 13 6 11 1 5 1 3 3 1 4 19 1 0 % 13 29 38 15 38 0 19 6 6 33 0 10 12 29 19 34 13 26 100 21 8 10 43 4 40 28 6 0
EB111/28 Add.1
3
4 WHO expert advisory panels Maternal and child health Mental health Neurosciences Nursing Nutrition Oral health Organization of medical care Parasitic diseases (filarial infections) Parasitic diseases (general parasitology) Parasitic diseases (leishmaniasis) Parasitic diseases (schistosomiasis) Parasitic diseases (trypanosomiases) Prevention of blindness Prevention of deafness and hearing impairment Public health administration Rabies Radiation Rehabilitation Respiratory infections Sexually transmitted infections including those due to human immunodeficiency virus Tobacco or health Traditional medicine Tuberculosis Vector biology and control Virus diseases Virus diseases (antivirals and interferon) Zoonoses Total Africa N 2 3 1 5 0 4 2 3 3 0 3 3 2 1 2 2 0 0 0 2 0 3 4 2 2 0 0 110 W 1 0 0 4 0 1 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 0 0 0 0 20 18%
EB111/28 Add.1
The Americas N W 4 12 2 9 5 1 3 2 6 1 9 13 7 3 5 4 1 1 0 6 2 4 7 10 7 2 2 272 0 2 0 9 0 0 0 1 2 0 0 5 2 0 1 0 0 0 0 1 0 1 1 0 0 0 0 63 23%
South-East Asia N W 3 5 2 5 2 4 2 2 2 2 0 0 2 1 2 1 2 1 0 2 1 2 2 6 4 0 2 118 1 3 1 5 0 2 0 0 1 0 0 0 0 1 0 0 1 1 0 0 0 0 0 2 1 0 0 31 26%
Europe N 1 18 8 1 6 12 10 4 16 8 9 7 4 4 2 1 6 0 1 5 2 0 8 13 9 2 4 406 W 1 3 1 1 2 1 0 0 2 0 0 0 0 1 0 0 0 0 0 1 1 0 3 1 1 0 0 58 14%
Eastern Mediterranean N W 6 3 1 7 4 3 1 0 2 0 4 0 1 1 8 1 1 1 0 0 0 1 3 5 2 0 1 111 2 0 0 7 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 22 14%
Western Pacific N W 2 12 2 4 4 2 1 1 3 0 8 0 5 2 1 1 0 3 2 4 1 4 5 8 5 0 1 168 2 3 0 4 0 0 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0 1 1 1 1 0 0 31 18%
Total N 18 53 16 31 21 26 19 12 32 11 33 23 21 12 20 10 10 6 3 19 6 14 29 44 29 4 10 1 185 W 7 11 2 30 3 4 0 3 5 0 1 5 3 2 1 1 1 2 0 2 1 2 8 5 3 0 0 225 % 39 21 13 97 14 15 0 25 16 0 3 22 14 17 5 10 10 33 0 11 17 14 28 11 10 0 0 19
= = =
N: total number of panel members W: number of women members %: percentage of women members by panel and region.